Lung Stereotactic Body Radiation Therapy (SBRT) dose gradient and PTV volume: a retrospective multi-center analysis

Autor: David J. Hoopes, Ryan P. Manger, Irena Dragojević, Jeremy D.P. Hoisak, D Hoffman
Rok vydání: 2019
Předmět:
Organs at Risk
Percentile
Lung Neoplasms
medicine.medical_treatment
Radiotherapy Planning
Retrospective
0302 clinical medicine
Computer-Assisted
Intensity-Modulated
Gradient index
Radiation treatment planning
Lung
Cancer
SBRT
Gradient measure
Lung Cancer
Radiotherapy Dosage
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Prognosis
Tumor Burden
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
Lung cancer
lcsh:Medical physics. Medical radiology. Nuclear medicine
Stereotactic body radiation therapy
lcsh:R895-920
Oncology and Carcinogenesis
Radiosurgery
lcsh:RC254-282
03 medical and health sciences
medicine
Humans
Radiology
Nuclear Medicine and imaging

Oncology & Carcinogenesis
Retrospective Studies
Radiotherapy
business.industry
Research
Radiotherapy Planning
Computer-Assisted

Dose gradient
medicine.disease
Radiation therapy
Radiotherapy
Intensity-Modulated

Nuclear medicine
business
Volume (compression)
Zdroj: Radiation oncology (London, England), vol 14, iss 1
Radiation Oncology, Vol 14, Iss 1, Pp 1-7 (2019)
Radiation Oncology (London, England)
Popis: Background The treatment of lung lesions with stereotactic body radiation therapy calls for highly conformal dose, which is evaluated by a number of metrics. Lung stereotactic body radiation therapy clinical trials constrain a plans gradient index. The purpose of this work is to describe the dependence of clinically achievable dose gradient on planning target volume. Methods Three hundred seventy-four lung stereotactic body radiation therapy treatment plans were retrospectively reviewed and selected for this study. The relationship between R50% and planning target volume size was observed and compared against the RTOG 0915 and 0813 constraints noting minor and major deviations. Then a least squares regression was used to determine the coefficients for a power functional form of the dependence of gradient measure (GM) on planning target volume size. Results Of the 317 peripheral lung SBRT plans, 142 exhibited no deviation, 135 exhibited a minor deviation, and 40 exhibited a major deviation according to the RTOG 0915 dosimetric. conformality and dose fall-off constraints. A plot of gradient measure versus planning target volume size for peripheral lesions, excluding RTOG 0915 major deviations, is fit with an power function of GM = 0.564 V0.215. Conclusions Using the PTV size and GM relationship we have characterized, treatment plans with PTV
Databáze: OpenAIRE